根据最新的SEC文件显示，总部位于北卡罗来纳州的制药公司Scorpius Holdings, ...

根据Scorpius Holdings, Inc.最近向美国证券交易委员会提交的8-K文件，这家市值136万美元的制药公司已通过向一家机构投资者发行不可转换本票签订了一项重大确定性协议。 根据 InvestingPro 的数据，该公司的短期债务目前超过其流动资产，流动比率为0.62。该本票于周四发行，本金金额为60万美元，年利率为5.0%。

In this episode, Dave Eicher invites you to go out and catch the Moon as it passes by Antares, the brightest star in the ...

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ...

A stellar nursery hidden in Scorpius, the Dark Tower is a glowing, wind-sculpted cloud of gas shaped by young stars’ ...

Scorpius Holdings, Inc., a pharmaceutical company with a market capitalization of $1.36 million, has entered into a material definitive agreement through the issuance of a non-convertible promissory ...

Scorpius Holdings, Inc. DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and ...

Treats are in store for stargazers at both ends of the short summer nights this June. Evenings belong to Saturn, a beacon in the southwest. Not sure which object is the ringed planet? Look the ...

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer.